Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON<sup>®</sup> Gold Testing Useful?

Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON<sup>®</sup> Gold Testing Useful?

Background—Tumour necrosis factor alpha (TNFα) plays an important role in the pathogenesis of inflammatory bowel disease (IBD) and in immunity to <i>Mycobacterium tuberculosis.</i> Patients should be tested for latent tuberculosis infection using interferon-gamma release assays (IGRA/QF)...

Full description

Bibliographic Details
Main Authors: Jessica Lovatt, Deborah Gascoyne-Binzi, Thomas Hussey, Maya Garside, Fiona McGill, Christian P. Selinger
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
inflammatory bowel disease
latent tuberculosis
QuantiFERON<b><sup>®</sup></b>
Online Access:https://www.mdpi.com/2077-0383/10/9/1816

Similar Items

Similar Items